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The year 2013 brought major modifications in ESCMID’s
publications. In fact, a new journal from the ESCMID has
been created; it is called New Microbes and New Infections, and
its Editor-in-Chief is Michel Drancourt, formerly associate
editor of CMI. The reason for the creation of this journal
was related to two factors: on the one hand, the increase in
rejections of high quality submissions to CMI raised the
question of a loss of ability to publish high-quality papers; on
the other hand, work by Evelina Tacconelli on mismatches
for acceptance rates for papers from emerging countries led
to editorial reflection with a themed section (Infection
problems in South-East Europe and neighbours. Clin Microbiol
Infect 2012; 18: 1053–1156), and partly a discussion in the
journal on this particular problem [1].
The solution to this problem was the creation of a new
journal that can directly receive from CMI items better
suited to its objective, which is the description of emerging
pathogens in countries where they were previously
unknown. This allows rapid publication and the first issue
has now been published. The new journal is managed by
Michel Drancourt, which led him to leave his position as
associate editor of CMI; he has been replaced by Mical Paul,
who invests heavily in the assessment of papers on research
in infectious diseases. Therefore, Evelina Tacconelli agreed
to be associate editor instead of Mical Paul and complete
our team.
The various topics covered by CMI are shown in Fig. 1, and
show a reasonable balance between the different sections
included in the journal. Themed sections attract attention to
the priorities of infectious disease physicians–they are a real
specificity of the journal. The rates of acceptance and rejection
are now stable, with an acceptance rate of approximately 20%
for original publications and research.
Finally, regarding the most cited articles, we see a significant
change in the journal, as the scope of CMI has changed over
the last 3 years, and this strategy is reflected in the most cited
articles (Table 8). Thus, among the most cited articles, four
concern virology, which was not previously in the spectrum of
the journal, three concern mycology, five concern antibiotics,
one concerns tropical pathology with leishmaniasis, and four
concern matrix-assisted laser desorption ionization time-of--
flight mass spectrometry, which is a new technology that has
stimulated many citations.
The Journal’s Editorial Structure
CMI appears monthly, and includes peer-reviewed manu-
scripts, reviews and research notes. Each print and online issue
includes a themed section. These are organized by a guest
editor, and cover key topics. They consist of three to five
invited reviews on the chosen topic, an editorial, and related
cover images. Table 2 shows all of the themed sections
published in 2013 and those scheduled for 2014.
Submissions
The proportion of manuscripts submitted as original
articles or as research notes (separate from invited reviews
and editorials) is continuously increasing. Also, these
manuscripts come from a large variety of countries
(Table 3); this shows that the journal is sought by many
authors in various countries, even though acceptance rates
are not currently equivalent for all countries. As compared
with 2011, it is interesting to note that new countries, such
as Madagascar, have managed to publish for the first time in
CMI. This clearly confirms the willingness of the journal to
be open to the world, including emerging countries. It is
also interesting to note that China and Taiwan are among
the top ten countries submitting papers to CMI. The journal
continues to make efforts to help improve papers coming
from countries with cultural and organizational difficulties,
with high scientific quality, allowing them to reach a
standard that is more consistent with the community’s
standards.
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Citations and Readership
CMI achieved some excellent results in the latest Journal
Citation Reports. The headline 2-year impact factor
increased by 0.8% to 4.578, and the 5-year impact factor
(which concerned citations in 2012 of items published in the
previous 5 years) showed an even greater increase, of 8.1%.
The journal’s immediacy index increased by over 25% for
2012. This measures citations in 2012 of papers published in
2012 (rather than in the previous 2 years), and so indicates
that CMI is publishing highly topical material that is being cited
very soon after publication. CMI also achieved significant
increases in its Eigen factor (up 11%) and article influence
score (up 8.2%), both of which are strong indicators of the
journal’s prestige within the scientific community.
As can be seen in Fig. 2, CMI’s impact factor has grown
substantially over the last decade, and remains well above the
aggregate and median levels for both of its subject categories.
The journal is currently ranked 11 of 69 journals in infectious
diseases, and 22 of 116 in microbiology.
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FIG. 1. The evolution of CMI’s thematic coverage between 2011 and 2012.
TABLE 1. Evolution of topics covered by CMI between 2011
and 2012 (publication ratios)
Ratio 2011 (%) Ratio 2012 (%)
Bacteriology 34.40 36.62
Epidemiology 10.10 11.27
Infectious diseases 21.20 16.43
Mycology 7.70 11.74
Virology 19.30 18.31
Tropical and parasitic diseases 7.40 5.63
TABLE 2. Themed sections published in CMI in 2013 and scheduled for 2014
Issue Guest editor Topic
CMI 2013 themed sections
January A. Guido Automation in molecular virology
February S. Cutler Multiple infections
March M. Drancourt Ocular infection
April D. Raoult and M. L. Paul Obesity and microbiology
May E. Bottieau Point of care for tropical countries
June G. Pappas Pig-related infection
July M. Paul Bacteraemia as a cause of death in modern countries
August T. Avsic-Zupanc Mosquito-transmitted diseases; relevance of bites; a new threat for Europe?
September P. E. Fournier and G. Greub Genomics in routine diagnostic laboratories—new techniques and
their application in clinical microbiology
October P. Parola The comeback of the big three killers (HIV/AIDS, tuberculosis, and malaria)
November M. Paul Predictions on infectious diseases
December M. Paul, P. T. Tassios and E. Roilides Guidelines, consensus, expert opinions, analysis, meta-analysis: who are
the experts? And how reliable are they?
CMI 2014 scheduled themed sections
January P. Brouqui Emerging technology in tracking contagion: a long journey for hand cleaning
in healthcare?
February M. Drancourt The discovery of major pathogens
March M. Paul Systematic reviews in infectious diseases
April E. Bottieau Parasitic diseases and immunosuppression
May R. Canton Antimicrobial susceptibility testing and clinical interpretation of antimicrobial
susceptibility testing data
June D. Raoult Emerging clones of bacterial epidemics
July L. Kaiser Norovirus
August M. Grobusch and G. Greub Bioterrorism
September G. Lina New epidemiology of Staphylococcus aureus infection
October A. Andremont and D. Raoult Faecal transplantation and infectious diseases physicians
November C. Pulcini and J. L. Mainardi Antimicrobial stewardship: an international emergency
December A. Guido and E. Roilides Host genetics and infections
These themed sections are also intended to highlight the fields and topics that we wish to publish on.
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The article that made the greatest contribution to the 2012
impact factor was ‘Evolving epidemiology of hepatitis C virus’
by D. Lavanchy [7], with more than 50 citations in 2012 alone.
Fourteen other articles published in the two survey years
achieved 20 or more citations in 2012.
Readership
As with citations, readership is another success story for
CMI. In the last full year (2012), total full-text downloads
increased by more than 30% on the prior year, to exceed
800,000. Early figures for 2013 suggest that this total will
increase again.
At the time of writing, the most downloaded article in 2013
was ‘Mesh-related infections after hernia repair surgery’ by
Falagas and Kasiakou [1], followed by ‘Multidrug-resistant,
extensively drug-resistant and pandrug-resistant bacteria: an
international expert proposal for interim standard definitions
for acquired resistance’ by Magiorakos et al. [2]. New publi-
cations and older articles are both strongly represented among
the top 50 most read.
Online Publications and Backlog
Management
The number of submitted papers has not diminished; there-
fore, the number of quality papers that we want to publish is
increasing, and, despite the increased online-only page budget,
the large volume of articles makes it difficult for the time to
publication in an issue to decrease. However, the time to Early
View publication has decreased to 48 days, down from
55 days in 2012. We consider that Early View publication is
essentially no different from final publication, as the article is
fully citable and searchable in PubMed.
Infection Hot Topics
From the start, this category has provided an immediate
platform for the entire editorial board, and is thus closer to
the discussions of the scientific community. This selection has
been a real success from the time of its establishment.
The Position of the Journal within
International Competition
CMI is going from strength to strength, achieving an impact
factor of 4.578 in the latest ISI Journal Citations Report,
ranking the journal at number 11 in the ISI infectious diseases
subject category. In 2012, CMI articles were downloaded
TABLE 3. Submissions and acceptance rates by country in
2012
Number of
submissions
Number of
accepted
manuscripts
Acceptance
ratio (%)
Spain 155 40 26
France 149 65 44
China 110 10 9
Italy 80 25 31
Taiwan 62 10 16
The Netherlands 60 15 25
USA 51 17 33
UK 49 17 35
Germany 45 15 33
Brazil 44 5 11
Switzerland 29 10 34
India 28 5 18
Republic of Korea 27 3 11
Australia 24 6 25
Greece 23 6 26
Turkey 23 5 22
Sweden 22 7 32
Denmark 21 11 52
Austria 20 6 30
Israel 20 9 45
Japan 18 3 17
Belgium 17 4 24
Canada 17 7 41
Islamic Republic of Iran 16 2 13
Portugal 16 3 19
Poland 13 0 0
Finland 11 4 36
Argentina 7 3 43
Czech Republic 7 0 0
Pakistan 7 0 0
Hong Kong 6 1 17
New Zealand 6 0 0
Croatia 5 3 60
Egypt 5 1 20
Tunisia 5 0 0
Lebanon 4 0 0
Russian Federation 4 1 25
Saudi Arabia 4 1 25
Slovenia 4 2 50
Colombia 3 0 0
Hungary 3 0 0
Ireland 3 1 33
Malaysia 3 0 0
Serbia 3 0 0
Singapore 3 0 0
Bangladesh 2 0 0
Bulgaria 2 0 0
Estonia 2 0 0
Gabon 2 1 50
Indonesia 2 0 0
Malta 2 1 50
Mexico 2 1 50
Morocco 2 0 0
Nigeria 2 0 0
Senegal 2 1 50
Thailand 2 0 0
Wallis and Futuna 2 1 50
Central African Republic 1 0 0
Costa Rica 1 0 0
Cyprus 1 0 0
Jordan 1 0 0
Luxembourg 1 0 0
Madagascar 1 1 100
Moldova 1 0 0
Norway 1 0 0
Peru 1 0 0
Romania 1 0 0
United Arab Emirates 1 1 100
Uruguay 1 0 0
Venezuela 1 0 0
Total 1269 330 26
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810 010 times, an increase of 31% as compared with 2011
(including third-party licences).
Future Evolution and Perspectives
For the next 2 years, we want to stabilize the current size of
the journal, in order to assess its real impact in the scientific
community. The journal will continue to have a themed section
per issue, as well as approximately ten original articles, on top
of which Research Notes and longer articles will be available
online. The journal also publishes supplementary issues
(Table 7) that reflect congresses organized by the ESCMID
(ECCMID), or conferences sponsored by partners; these
0.000
1.000
2.000
3.000
4.000
5.000
6.000
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
2002-2012 Impact factors
Infectious diseases median impact factor Infectious diseases aggregate impact factor
Microbiology median impact factor Microbiology aggregate impact factor
Clinical Microbiology and Infection
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TABLE 4. Year-by-year production summary
Year Volume(s) No. of issues No. of pages No. of articles
Average no. of days from receipt at
Wiley-Blackwell
Online publication Print publication
2013 1 12 1800 316 212a 218a
2012 1 12 1804 333 175b 183b
2011 1 12 1912 349 159 170
2010 1 12 1798 319 101 217
2009 1 12 1194 200 82 90
2008 1 12 1200 206 58 66
2007 1 12 1244 232 80 88
2006 1 12 1266 242 83 91
aPrediction based on current workflow.
bClearance of backlog.
TABLE 6. Most downloaded articles in 2012
Authors Article title Volume Issue Full text accessed Ref.
M. E. Falagas and S. K. Kasiakou Mesh-related infections after hernia repair surgery 11 1 10 416 1
A.-P. Magiorakos et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria 18 3 7273 2
B.A. Cunha The diagnostic significance of relative bradycardia in infectious disease 6 12 4169 3
D. Hill and J. P. Dubey Toxoplasma gondii: transmission, diagnosis, and prevention 8 10 3651 4
P. C. Y. Woo et al. Then and now: use of 16S rDNA gene sequencing for bacterial identification
and discovery of novel bacteria in clinical microbiology laboratories
14 10 3101 5
M. Woodhead et al. Guidelines for the management of adult lower respiratory tract infections 17 s6 3065 6
D. Lavanchy Evolving epidemiology of hepatitis C virus 17 2 2793 7
D. Yahav et al. Colistin: new lessons on an old antibiotic 18 1 264 8
J. W. Mouton et al. The role of pharmacokinetics/pharmacodynamics in setting clinical MIC
breakpoints: the EUCAST approach
18 3 2612 9
L. Poirel and P. Nordmann Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology 12 9 2242 10
TABLE 7. Supplements published in CMI in 2012 and 2013
Author Topic Issue Online date Print Sponsor
Number
of paper Ref.
Supplements in 2012
C. Pelucchi et al. ESCMID Guidelines for the Management of
Acute Sore Throat
18 s1
pp. 1–28
21 March 2012 April 2012 ESCMID 1 11
Y. Hicheri et al. Antifungal prophylaxis in haematology patients:
the role of voriconazole
18 s2
pp. 1–15
12 March 2012 April 2012 Pfizer
International
Operations
1 12
Abstracts of the 22nd European Congress of
Clinical Microbiology and Infectious Diseases,
London, UK, 31 March to 3 April 2012
18 s3
pp. 1–902
1 April 2012 April 2012 ESCMID 4 13
Edited by A. Moya,
R. Canton and D. Raoult
Microbiome: deciphering the last human body
organ
18 s4
p. 1
31 May 2012 July 2012 Fundacion Lilly 18 14
Edited by M. Paul The impact of vaccines on public health 18 s5
pp. 1–122
6 August 2012 October 2012 ESCMID 16 15
Edited by F. Fitzpatrick,
F. Barbut and F. Allerberger
Breaking the cycle of recurrent Clostridium
difficile infections
Satellite Symposium at ESCMID 2012 Excel
Centre, London
18 s6 November 2012 December 2012 Astellas 6 16
ESCMID publications ESCMID Guideline for the Diagnosis and
Management of Candida Diseases
18s7 25 September 2012 December 2012 ESCMID 6 17
Supplements in 2013
P. Durando et al. Experience with pneumococcal polysaccharide
conjugate vaccine (conjugated to CRM197 carrier
protein) in children and adults
19 s1 2 October 2013 Pfizer 9 18
TABLE 5. Acceptance and rejection rates for Original Articles and Research Notes since 2008
Decision made Accepted Acceptance rate (%) Rejected Rejection rate (%)
2008 826 240 29 586 71
2009 779 208 27 571 73
2010 995 239 24 756 76
2011 1138 214 19 924 81
2012 1177 244 21 933 79
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supplements also enjoy a relatively large number of citations.
The supplementary issues have been managed by the
Editorial Board since 2010. Table 2 lists the supplementary
issues that were published in 2013 and that are scheduled
for 2014.
The Journal’s Most Cited Articles
The articles in Table 8 made the greatest contribution to the
2012 impact factor, i.e. articles published in 2010 and 2011 that
received the most citations in 2012.
Workflow—Evolution Since 2009
The current processing time for manuscripts has continued to
improve since 2009 (Table 9). In 2012, this averaged 29 days;
this is broken down into 7 days for immediate rejection, and
44 days for a decision of acceptance, revision or rejection after
peer-review, which, at present, appears reasonable.
The average time between final acceptance and the first
online publication is 1 week for the accepted manuscript as
supplied by the author, and 7 weeks for the version copy-edited
and typeset by the publisher. For articles published this year, the
average time to publication in an issue is 4.25 months. The aim
remains for the print version to be available within 3–4 months
after final acceptance. After an average processing time of
4.5 months between acceptance and final publication over the
last five, this objective is currently being achieved.
Conclusion
The ambition of CMI is to reflect the academic activities of the
ESCMID, and more generally of the world of infectious
TABLE 8. 2010 and 2011 papers with most citations in 2012
Author(s) Title
Document
type
Publication
year
Volume
(Issue)
No. of
times
cited Ref.
Lavanchy Evolving epidemiology of hepatitis C virus Review 2011 17 (2) 52 7
Allerberger and Wagner Listeriosis: a resurgent foodborne infection Review 2010 16 (1) 34 19
Bizzini and Greub Matrix-assisted laser desorption ionization time-of-flight mass
spectrometry, a revolution in clinical microbial identification
Review 2010 16 (11) 33 20
Leverstein-van Hall et al. Dutch patients, retail chicken meat and poultry share the same
ESBL genes, plasmids and strains
Article 2011 17 (6) 31 21
Miriagou et al. Acquired carbapenemases in Gram-negative bacterial pathogens:
detection and surveillance issues
Article;
proceedings
paper
2010 16 (2) 31 22
Gould et al. First cases of autochthonous dengue fever and chikungunya fever in
France: from bad dream to reality!
Editorial
material
2010 16 (12) 29 23
Vermehren and Sarrazin New hepatitis C virus therapies on the horizon Review 2011 17 (2) 25 24
Carmeli et al. Controlling the spread of carbapenemase-producing Gram-negatives:
therapeutic approach and infection control
Article;
proceedings
paper
2010 16 (2) 24 25
Croft and Olliaro Leishmaniasis chemotherapy—challenges and opportunities Review 2011 17 (10) 23 26
Moussaoui et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry
identifies 90% of bacteria directly from blood culture vials
Article 2010 16 (11) 23 27
Denkinger et al. Guidelines on interferon-c release assays for tuberculosis infection:
concordance, discordance or confusion?
Review 2011 17 (6) 21 28
Woodhead et al. Guidelines for the management of adult lower respiratory tract
infections—full version
Article 2011 17 (6) 21 29
Bader et al. Improved clinical laboratory identification of human pathogenic yeasts by
matrix-assisted laser desorption ionization time-of-flight mass spectrometry
Article 2011 17 (9) 20 30
Skiada et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the
European Confederation of Medical Mycology (ECMM) Working Group on
Zygomycosis between 2005 and 2007
Article 2011 17 (12) 20 31
Guinea et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease:
incidence, risk factors, and outcome
Article 2010 16 (7) 20 32
Casalegno et al. Rhinoviruses delayed the circulation of the pandemic influenza A (H1N1)
2009 virus in France
Article 2010 16 (4) 19 33
Hegstad et al. Mobile genetic elements and their contribution to the emergence of
antimicrobial-resistant Enterococcus faecalis and Enterococcus faecium
Review 2010 16 (6) 19 34
Murray Matrix-assisted laser desorption ionization time-of-flight mass spectrometry:
usefulness for taxonomy and epidemiology
Review 2010 16 (11) 19 35
Stanek et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe Article 2011 17 (1) 18 36
Linares et al. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus
pneumoniae over a 30-year period
Review 2010 16 (5) 18 37
TABLE 9. Evolution of the processing time for the treat-
ment of manuscripts since 2009
Average number of days between
submission and decision 2009 2010 2011 2012 2013a
Immediate rejection 17 11 9 7 6
Decision after peer review
(accept, revision, reject)
63 44 31 44 68
Average processing time 40 27 20 29 37
aUp to 24 September 2013.
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diseases and clinical microbiology, as well as to attract the best
publications and reviews within the field. It also aims to attract
attention to emerging fields or questions based on the focus
provided by themed sections.
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